Condition: Multiple Myeloma · Hematopoietic Stem Cell Mobilization · Sponsor: The Affiliated People's Hospital of Ningbo University
This is a prospective, randomized, two-arm, multicenter, exploratory study aimed at evaluating the efficacy and safety of the combination of etoposide, cytarabine and Pegfilgrastim (EAP regimen) for mobilizing hematopoietic stem cells in patients with newly diagnosed multiple myeloma (NDMM). A total of 99 NDMM patients will be enrolled and randomly assigned to receive either the EAP regimen or the GC regimen (cyclophosphamide+ G-CSF) to mobilize hematopoietic stem cells. Subsequently, the mobilization effects and adverse reactions of all patients will be observed and compared.
This description comes directly from the study's public registry record.
Ying Lu · +86-13486090834 · 814871416@qq.com
Peipei Ye · +86-13685832706 · 39612903@qq.com
Always discuss trial participation with your own doctor first.
| Dongyang People's Hospital | Dongyang, Zhejiang, China | Recruiting |
| The First Affiliated Hospital, College of Medicine, Zhejiang University | Hangzhou, Zhejiang, China | Recruiting |
| Tongde Hospital of Zhejiang Province | Hangzhou, Zhejiang, China | Recruiting |
| Huzhou central hospital | Huzhou, Zhejiang, China | Recruiting |
| The First Hospital of Jiaxing | Jiaxing, Zhejiang, China | Recruiting |
| Jinhua Municipal Central Hospital | Jinhua, Zhejiang, China | Recruiting |
| Jinhua People's Hospital | Jinhua, Zhejiang, China | Recruiting |
| Lishui Central Hospital | Lishui, Zhejiang, China | Recruiting |
| Ningbo Medical Center Lihuili Hospital | Ningbo, Zhejiang, China | Recruiting |
| The Affiliated People's Hospital of Ningbo University | Ningbo, Zhejiang, China | Recruiting |
| Shaoxing People's Hospital | Shaoxing, Zhejiang, China | Recruiting |
| Shaoxing Second Hospital | Shaoxing, Zhejiang, China | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06520176